A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 29, Issue 4, Pages 1446-1455
Publisher
FASEB
Online
2014-12-31
DOI
10.1096/fj.14-263053
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
- (2013) In-Young Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor
- (2013) Derek M. Shore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Quantification of a New Family of Peptide Endocannabinoids (Pepcans) Showing Negative Allosteric Modulation at CB1Receptors
- (2012) Mark Bauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Best of Both Worlds? Bitopic Orthosteric/Allosteric Ligands of G Protein–Coupled Receptors
- (2011) Celine Valant et al. Annual Review of Pharmacology and Toxicology
- Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice
- (2010) Courtney D. Netherland et al. ATHEROSCLEROSIS
- Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities
- (2010) Barbara Bosier et al. BIOCHEMICAL PHARMACOLOGY
- Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes
- (2010) Ryuichiro Murakami et al. LIFE SCIENCES
- Effects of the Allosteric Antagonist 1-(4-Chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 Receptor Modulation in the Cerebellum
- (2010) X. Wang et al. MOLECULAR PHARMACOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Pharmacological characterization of GPR55, a putative cannabinoid receptor
- (2010) Haleli Sharir et al. PHARMACOLOGY & THERAPEUTICS
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice
- (2009) n. l. cluny et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
- (2008) Celine Valant et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibrates and future PPARα agonists in the treatment of cardiovascular disease
- (2008) Bart Staels et al. Nature clinical practice. Cardiovascular medicine
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
- PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
- (2007) J G Horswill et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search